Adenovirus formulations

Details for Australian Patent Application No. 2006202389 (hide)

International Classifications

Event Publications

22 June 2006 Complete Application Filed

29 June 2006 Application Open to Public Inspection

Published as AU-B-2006202389

25 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 February 2008 Section 223 Application Received

Merck & Co., Inc. An application to extend the time from 06 Mar 2007 to 06 Nov 2007 in which to pay a continuation fee has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

17 April 2008 Section 223 Application Allowed

Merck & Co., Inc. The time in which to pay a continuation fee has been extended to 06 Nov 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

8 January 2009 Application Accepted

Published as AU-B-2006202389

7 May 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.